lactoperoxidase Inhibitors

Lactoperoxidase inhibitors constitute a chemical class of compounds designed to modulate the activity of lactoperoxidase (LPO), an enzyme present in various biological systems, including saliva, milk, and mucous secretions. LPO serves as a crucial component of the innate immune system, participating in host defense mechanisms against pathogens. The primary function of LPO is to catalyze the oxidation of substrates, typically thiocyanate and iodide ions, in the presence of hydrogen peroxide (H2O2), generating antimicrobial compounds like hypothiocyanite and hypoiodite. LPO inhibitors, therefore, play a vital role in regulating this enzyme's activity.

These inhibitors employ diverse mechanisms to interfere with LPO's function. Some, like thiocyanate ions and 4-aminobenzoic acid, act as competitive inhibitors by binding to the active site of LPO, preventing it from oxidizing substrates efficiently. Others, such as azide and cyanide ions, disrupt LPO's catalytic activity by binding to its heme group, essential for its function. Additionally, hydrogen peroxide, while being a substrate for LPO, can act as an inhibitor when present in excess, competing with other substrates and potentially blocking the enzyme's active site. Overall, LPO inhibitors regulate the release of antimicrobial compounds and the oxidative processes associated with LPO, influencing its role in innate immunity and related biological functions.